Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 01/25/24 07:00:42 on US and Canada Markets.
NEW YORK, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Valley National Bancorp ( NASDAQ:VLY ), the holding company for Valley National Bank, today reported net income for the fourth quarter 2023 of $71.6 million, or $0.13 per diluted common share, as compared to the fourth quarter 2022 net income of...
BOSTON and LONDON, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a global gene therapy leader, today announced the company has reached an agreement with the Beneluxa Initiative on Pharmaceutical Policy (Beneluxa) enabling reimbursed access to Libmeldy ® (atidarsagene autotemcel...
Collaboration will support the initiation of a combination arm in the ongoing Phase 1/2a trial in patients with mCRPC Enrollment will continue in the monotherapy and IL-2 combination arms of the study UTRECHT, The Netherlands and PHILADELPHIA, Jan. 25, 2024 (GLOBE NEWSWIRE) -- LAV...
Interim Data Analysis Anticipated in Mid-2024 Expects Full Enrollment by Q1 2025 MINNEAPOLIS, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc . (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent u...
Lixiang Education Regains Compliance with Nasdaq Minimum Bid Price Requirement PR Newswire LISHUI, China , Jan. 25, 2024 /PRNewswire/ -- Lixiang Education Holding Co., Ltd. (the "Company" or NASDAQ: LXEH), a prestigious private education service provider in Chi...
Corsair Gaming, Inc. (Nasdaq: CRSR) (“Corsair” or the “Company”), a leading global provider and innovator of high-performance gear for gamers, streamers, content-creators, and gaming PC builders, today announced it will release its fourth quarter and full year 2023 res...
Milestone payment triggered by dosing of the first patient in camonsertib-based arm in Roche’s Phase 2 TAPISTRY platform clinical trial Repare is eligible to receive up to $1.2 billion in potential milestones, plus royalties on global net product sales Repare Therapeutics...
Diana Hausman, M.D., Accomplished Oncologist and Drug Developer, Appointed Chief Medical Officer Kyle Rasbach, Ph.D., Pharm.D., Experienced Biotechnology Portfolio Manager, Appointed Chief Business Officer NEW YORK and SAN DIEGO, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Zentalis ®...
LITTLETON, Colo., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Breckenridge Brewery (“Breck Brewery” or “Breck Brew”) a subsidiary of Tilray Brands, Inc . (“Tilray” or the “Company”) (NASDAQ: TLRY and TSX: TLRY), is thrilled to introduce i...
TORONTO, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that its brand, Spinach ® , closed 2023 as the number one ranked flower brand in...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
7.88%Change Percent:
Heineken Holding NV Company Name:
HKHHF Stock Symbol:
OTCMKTS Market:
heinekenholding.com Website: